Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Gómez de Cedrón M[au]:

Lipid metabolism and lung cancer. Merino Salvador M et al. Crit Rev Oncol Hematol. (2017)

MicroRNA-661 modulates redox and metabolic homeostasis in colon cancer. Gómez de Cedrón M et al. Mol Oncol. (2017)

Microtargeting cancer metabolism: opening new therapeutic windows based on lipid metabolism. Gómez de Cedrón M et al. J Lipid Res. (2016)

Search results

Items: 21

1.

The specific seroreactivity to ∆Np73 isoforms shows higher diagnostic ability in colorectal cancer patients than the canonical p73 protein.

Garranzo-Asensio M, Guzmán-Aránguez A, Povés C, Fernández-Aceñero MJ, Montero-Calle A, Ceron MÁ, Fernandez-Diez S, Rodríguez N, Gómez de Cedrón M, Ramírez de Molina A, Domínguez G, Barderas R.

Sci Rep. 2019 Sep 19;9(1):13547. doi: 10.1038/s41598-019-49960-x.

2.

Tolerability and Safety of a Nutritional Supplement with Potential as Adjuvant in Colorectal Cancer Therapy: A Randomized Trial in Healthy Volunteers.

Gómez de Cedrón M, Laparra JM, Loria-Kohen V, Molina S, Moreno-Rubio J, Montoya JJ, Torres C, Casado E, Reglero G, Ramírez de Molina A.

Nutrients. 2019 Aug 24;11(9). pii: E2001. doi: 10.3390/nu11092001.

3.

Yarrow supercritical extract exerts antitumoral properties by targeting lipid metabolism in pancreatic cancer.

Mouhid L, Gómez de Cedrón M, García-Carrascosa E, Reglero G, Fornari T, Ramírez de Molina A.

PLoS One. 2019 Mar 26;14(3):e0214294. doi: 10.1371/journal.pone.0214294. eCollection 2019.

4.

Identification of antitumoral agents against human pancreatic cancer cells from Asteraceae and Lamiaceae plant extracts.

Mouhid L, Gómez de Cedrón M, Vargas T, García-Carrascosa E, Herranz N, García-Risco M, Reglero G, Fornari T, Ramírez de Molina A.

BMC Complement Altern Med. 2018 Sep 17;18(1):254. doi: 10.1186/s12906-018-2322-6.

5.

Novel Polyphenols That Inhibit Colon Cancer Cell Growth Affecting Cancer Cell Metabolism.

Gómez de Cedrón M, Vargas T, Madrona A, Jiménez A, Pérez-Pérez MJ, Quintela JC, Reglero G, San-Félix A, Ramírez de Molina A.

J Pharmacol Exp Ther. 2018 Aug;366(2):377-389. doi: 10.1124/jpet.118.248278. Epub 2018 Jun 5.

PMID:
29871992
6.

Targeting the lipid metabolic axis ACSL/SCD in colorectal cancer progression by therapeutic miRNAs: miR-19b-1 role.

Cruz-Gil S, Sanchez-Martinez R, Gomez de Cedron M, Martin-Hernandez R, Vargas T, Molina S, Herranz J, Davalos A, Reglero G, Ramirez de Molina A.

J Lipid Res. 2018 Jan;59(1):14-24. doi: 10.1194/jlr.M076752. Epub 2017 Oct 26.

7.

MicroRNA-661 modulates redox and metabolic homeostasis in colon cancer.

Gómez de Cedrón M, Acín Pérez R, Sánchez-Martínez R, Molina S, Herranz J, Feliu J, Reglero G, Enríquez JA, Ramírez de Molina A.

Mol Oncol. 2017 Dec;11(12):1768-1787. doi: 10.1002/1878-0261.12142. Epub 2017 Nov 6.

8.

Lipid metabolism and lung cancer.

Merino Salvador M, Gómez de Cedrón M, Moreno Rubio J, Falagán Martínez S, Sánchez Martínez R, Casado E, Ramírez de Molina A, Sereno M.

Crit Rev Oncol Hematol. 2017 Apr;112:31-40. doi: 10.1016/j.critrevonc.2017.02.001. Epub 2017 Feb 13. Review. Erratum in: Crit Rev Oncol Hematol. 2019 Jan;133:45.

PMID:
28325263
9.

Genetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene Expression.

Bueno MJ, Pérez de Castro I, Gómez de Cedrón M, Santos J, Calin GA, Cigudosa JC, Croce CM, Fernández-Piqueras J, Malumbres M.

Cancer Cell. 2016 Apr 11;29(4):607-608. doi: 10.1016/j.ccell.2016.03.013. No abstract available.

10.

microRNAs regulate TAL1 expression in T-cell acute lymphoblastic leukemia.

Correia NC, Melão A, Póvoa V, Sarmento L, Gómez de Cedrón M, Malumbres M, Enguita FJ, Barata JT.

Oncotarget. 2016 Feb 16;7(7):8268-81. doi: 10.18632/oncotarget.6987.

11.

Microtargeting cancer metabolism: opening new therapeutic windows based on lipid metabolism.

Gómez de Cedrón M, Ramírez de Molina A.

J Lipid Res. 2016 Feb;57(2):193-206. doi: 10.1194/jlr.R061812. Epub 2015 Dec 2. Review.

12.

A link between lipid metabolism and epithelial-mesenchymal transition provides a target for colon cancer therapy.

Sánchez-Martínez R, Cruz-Gil S, Gómez de Cedrón M, Álvarez-Fernández M, Vargas T, Molina S, García B, Herranz J, Moreno-Rubio J, Reglero G, Pérez-Moreno M, Feliu J, Malumbres M, Ramírez de Molina A.

Oncotarget. 2015 Nov 17;6(36):38719-36. doi: 10.18632/oncotarget.5340.

13.

The ellagic acid derivative 4,4'-di-O-methylellagic acid efficiently inhibits colon cancer cell growth through a mechanism involving WNT16.

Ramírez de Molina A, Vargas T, Molina S, Sánchez J, Martínez-Romero J, González-Vallinas M, Martín-Hernández R, Sánchez-Martínez R, Gómez de Cedrón M, Dávalos A, Calani L, Del Rio D, González-Sarrías A, Espín JC, Tomás-Barberán FA, Reglero G.

J Pharmacol Exp Ther. 2015 May;353(2):433-44. doi: 10.1124/jpet.114.221796. Epub 2015 Mar 10.

PMID:
25758919
14.

Cdk4 and Cdk6 cooperate in counteracting the INK4 family of inhibitors during murine leukemogenesis.

Rodríguez-Díez E, Quereda V, Bellutti F, Prchal-Murphy M, Partida D, Eguren M, Kollmann K, Gómez de Cedrón M, Dubus P, Cañamero M, Martínez D, Sexl V, Malumbres M.

Blood. 2014 Oct 9;124(15):2380-90. doi: 10.1182/blood-2014-02-555292. Epub 2014 Aug 25.

PMID:
25157181
15.

Combinatorial effects of microRNAs to suppress the Myc oncogenic pathway.

Bueno MJ, Gómez de Cedrón M, Gómez-López G, Pérez de Castro I, Di Lisio L, Montes-Moreno S, Martínez N, Guerrero M, Sánchez-Martínez R, Santos J, Pisano DG, Piris MA, Fernández-Piqueras J, Malumbres M.

Blood. 2011 Jun 9;117(23):6255-66. doi: 10.1182/blood-2010-10-315432. Epub 2011 Apr 8.

PMID:
21478429
16.

Multiple E2F-induced microRNAs prevent replicative stress in response to mitogenic signaling.

Bueno MJ, Gómez de Cedrón M, Laresgoiti U, Fernández-Piqueras J, Zubiaga AM, Malumbres M.

Mol Cell Biol. 2010 Jun;30(12):2983-95. doi: 10.1128/MCB.01372-09. Epub 2010 Apr 19.

17.

Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression.

Bueno MJ, Pérez de Castro I, Gómez de Cedrón M, Santos J, Calin GA, Cigudosa JC, Croce CM, Fernández-Piqueras J, Malumbres M.

Cancer Cell. 2008 Jun;13(6):496-506. doi: 10.1016/j.ccr.2008.04.018. Erratum in: Cancer Cell. 2016 Apr 11;29(4):607-8.

18.

Genetic analysis of the function of the plum pox virus CI RNA helicase in virus movement.

Gómez de Cedrón M, Osaba L, López L, García JA.

Virus Res. 2006 Mar;116(1-2):136-45. Epub 2005 Oct 26.

PMID:
16256236
19.

RNA helicase activity of Semliki Forest virus replicase protein NSP2.

Gomez de Cedrón M, Ehsani N, Mikkola ML, García JA, Kääriäinen L.

FEBS Lett. 1999 Apr 1;448(1):19-22.

20.

The motif V of plum pox potyvirus CI RNA helicase is involved in NTP hydrolysis and is essential for virus RNA replication.

Fernández A, Guo HS, Sáenz P, Simón-Buela L, Gómez de Cedrón M, García JA.

Nucleic Acids Res. 1997 Nov 15;25(22):4474-80.

21.

Population study of 3 STR loci in the Basque Country (northern Spain).

Alonso S, Castro A, Fernandez I, Gómez de Cedrón M, Garcia-Orad A, Meyer E, Martínez de Pancorbo M.

Int J Legal Med. 1995;107(5):239-45.

PMID:
7632600

Supplemental Content

Loading ...
Support Center